Michael W. Fountain, PhD, MBA
Scientific Advisor & Innovator of Lyphazome® Nanotechnology – Dermazone Solutions
Director, Center for Entrepreneurship - University of South Florida
Dr. Fountain currently serves as the Founding Director of the University of South Florida’s (USF) Interdisciplinary, Cross-Campus Center for Entrepreneurship, where he directs the University-wide Undergraduate and Graduate interdisciplinary programs in Entrepreneurship, the Interdisciplinary USF Graduate Certificate in Entrepreneurship and the Master of Science Degree in Entrepreneurship in Applied Technologies and graduate training programs in entrepreneurship for business, engineering, medical and sustainability students. He also serves as the faculty Director for the USF Student Innovation Incubator. He holds faculty senior faculty appointments in the Colleges of Business (John and Beverley Grant Endowed Chair), Medicine (Professor), Pharmacy (Professor), Engineering (Professor) and the Institute for Advanced Discovery and Innovation (Professor). Under Dr. Fountain’s direction, the Center for Entrepreneurship has developed national and international prominence as evidenced by top United States Association for Small Business and Entrepreneurship (USASBE) national awards (Model Specialty Program, Innovative Pedagogy and Innovative New Course) in 2004, 2005, and 2006, the USASBE Conference Pillar Award in Pedagogy in 2009 and national ranking by Princeton Review and Entrepreneur Magazine as one of the nation’s top graduate entrepreneurship education programs for the past consecutive 11 years. In 2017, The Association for the Advancement of Colleges and Schools of Business (AACSB) selected the Entrepreneurship Education Program at USF as one of the top 15 entrepreneurship educational programs in the world in the Entrepreneurship Spotlight Challenge.
In 2009 Dr. Fountain was honored as one of the top 100 business leaders in Tampa Bay by Tampa Bay CEO. Dr. Fountain has served as the Director of the National Consortium for Life Sciences Entrepreneurship and as an Entrepreneur-in-Residence with the Kauffman Foundation. He served for 4 years as the Vice President for Development of USASBE, 2 years as a Board Member-at-Large. He served as the National Director of the National Consortium for Life Sciences Entrepreneurship from 1999 until 2004, as an Entrepreneur-in-Residence at the Ewing Marion Kauffman Foundation and as a member of the Board for the Kauffman Fellows Program prior to becoming the Founding Center Director at USF. He is a pioneer in the development and adoption of Life Sciences Entrepreneurship as a sub-interdisciplinary specialty in entrepreneurship education linking the disciplines of science, medicine, engineering, sustainability and business. He was honored by USF receiving the university-wide Excellence in Research and Innovation Award for 2014, was selected as a 2015 Fellow in the National Academy of Inventors and selected in 2016 as a Justin Longenecker Fellow of USASBE.
Dr. Fountain has focused the past thirty-five years on creating, financing, growing and harvesting biotechnology, medical device and life science companies. In his career prior to coming to USF, Dr. Fountain founded or co-founded eleven new ventures, three of which became publicly traded companies. These corporate ventures include The Liposome Company, Cooper Biomedical, Lipogen, DFW Technologies, Inc., and Fountain Pharmaceuticals among others. During his corporate career he has served in a variety of leadership roles including Chief Scientific Officer, Chief Executive Officer and Chairman of the Board. Dr. Fountain was a pioneer in the field of development and application of the use of phospholipids in micro- and nano-particle technologies for drug encapsulation. He has successfully patented and commercialized numerous innovative medical and diagnostic products for the domestic and international marketplace, including sustained release anti-cancer drugs, genetically engineered diagnostic products for autoimmune diseases, microencapsulated dermatologic products and advanced subunit vaccine products for preventing human and animal infectious disease. His research efforts have yielded over 70 peer-reviewed publications, over 70 United States and International issued patents. His patented technology platforms are currently utilized in over 100 products worldwide. He currently serves as the Founder and Managing Partner for Fountain Technologies International, Board of Directors of Global Safety Management, Founder and Board of Directors of UVentures, Scientific Advisor of Dermazone Solutions, Inc and NuVessl, LLC. In addition, he serves on the Research Advisory Board of Auburn University.
Dr. Fountain received his Honors BS from Samford University, his MS and PhD from Auburn University and his MBA from Bristol University. In addition, he completed advanced studies in Education Theory at the University of South Florida.